Cargando…

Genetics of Cardiovascular Disease

Detalles Bibliográficos
Autor principal:	Stavljenic-Rukavina, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2003
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169145/ https://www.ncbi.nlm.nih.gov/pubmed/30302075

Ejemplares similares

Molecular Mechanisms in Alzheimer's Disease
por: Stavljenic–Rukavina, Ana
Publicado: (2004)

1. Prenatal Diagnosis of Chromosomal Disorders - Molecular Aspects
por: Stavljenić-Rukavina, Ana
Publicado: (2008)

5. Hereditary Kidney Disorders
por: Stavljenić-Rukavina, Ana
Publicado: (2009)

Ethnic Disparities in Treatment of Chronic Pain in Individuals with Parkinson's Disease Living in the United Kingdom
por: Rukavina, Katarina, et al.
Publicado: (2022)

Strategy of Prevention of Cardiovascular Disease
por: Kovács, Gábor L., et al.
Publicado: (2003)

Diabetes Mellitus and Cardiovascular Disease
por: Aganovic, Izet
Publicado: (2003)

Rational Diagnosis of Cardiovascular Disease
por: Müller, Mathias M., et al.
Publicado: (2003)

Atherothrombosis: Pathogenesis of Cardiovascular Disease
por: Mojca, Stegnar
Publicado: (2003)

The Role of Pharmacogenetics in Management of Cardiovascular Disease
por: Topic, Elizabeta
Publicado: (2003)

Pathophysiology and Classification of Cardiovascular Diseases Caused by Atherosclerosis
por: Reiner, Željko
Publicado: (2003)

Psychological and psychopathological sequelae in cardiovascular acute disease
por: Caponnetto, Pasquale
Publicado: (2018)

Evidence Based Laboratory Medicine in the Diagnosis of Metabolic Syndrome
por: Stavljenić-Rukavin, Ana, et al.
Publicado: (2007)

Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017)

Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide
por: Verma, Subodh, et al.
Publicado: (2021)

Diverse SARS-CoV-2 variants preceded the initial COVID-19 outbreak in Croatia
por: Rokić, Filip, et al.
Publicado: (2021)

Willis-Ekbom disease is not associated with poor cardiovascular health in adults
por: Dredla, Brynn K., et al.
Publicado: (2015)

Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases
por: Delbaere, Quentin, et al.
Publicado: (2023)

Hot Flashes and Cardiovascular Disease Risk Indices Among Women With HIV
por: Toribio, Mabel, et al.
Publicado: (2021)

Age-period-cohort Analysis of Cardiovascular Disease Mortality in Japan, 1995-2018
por: Okui, Tasuku
Publicado: (2020)

The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis
por: Deodhar, Atul, et al.
Publicado: (2016)

The Association Between Type 2 Diabetes and Cardiovascular Disease: The “For Your SweetHeart™” Survey
por: Perreault, Leigh, et al.
Publicado: (2019)

Cardiovascular Disease in Patients with Type 2 Diabetes and in Patients Starting Empagliflozin Treatment: Nationwide Survey
por: Eliasson, Björn, et al.
Publicado: (2019)

Age- and sex-dependent changes of resting amygdalar activity in individuals free of clinical cardiovascular disease
por: Haider, Ahmed, et al.
Publicado: (2021)

Vascular age, cardiovascular disease risk factors, and hematological parameters in patients with Schizophrenia: An exploratory study
por: Vyas, Hridyanshu, et al.
Publicado: (2023)

Glucose metabolism in cardiovascular surgery
por: Lazzeri, C, et al.
Publicado: (2010)

Heritability estimation of conventional cardiovascular disease risk factors in Asian Indian families: The Calcutta family study
por: Ghosh, Arnab, et al.
Publicado: (2010)

Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options
por: Rizvi, Ali A., et al.
Publicado: (2021)

Dose‐response association between step count and cardiovascular disease risk markers in middle‐aged adults
por: Hamer, Mark, et al.
Publicado: (2022)

Genetic clues for predisposition to severe disease
por: Flemming, Alexandra
Publicado: (2021)

Treatment of Lipid Disorders in Cardiovascular Patients
por: Williams, David L.
Publicado: (2003)

Phosphomevalonate kinase deficiency expands the genetic spectrum of systemic autoinflammatory diseases
por: Berner, Jakob, et al.
Publicado: (2023)

Serum Cystatin C, a Sensitive Marker of Renal Function and Cardiovascular Disease, Decreases After Smoking Cessation
por: Funamoto, Masafumi, et al.
Publicado: (2019)

Circulating Cytokine Levels and Cardiovascular Disease Risk Profile in Young Adult Offspring of Women with Type 1 Diabetes
por: Somersalo, Erik, et al.
Publicado: (2023)

Patient Perception of Cardiovascular Risk in Rheumatoid Arthritis
por: Banerjee, Shubhasree, et al.
Publicado: (2020)

Modifiable cardiovascular disease risk factors as predictors of dementia death: pooling of ten general population-based cohort studies
por: Batty, G David, et al.
Publicado: (2014)

The Effects of a Novel High Intensity Exercise Intervention on Established Markers of Cardiovascular Disease and Health in Scottish Adolescent Youth
por: Buchan, Duncan S., et al.
Publicado: (2012)

Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials
por: Verma, Subodh, et al.
Publicado: (2020)

New Markers for Cardiovascular Disease in Psoriatic Patients: Preliminary Study on Monocyte Phenotype, ADAMTS7, and mTOR Activity
por: Loyola, Khanty, et al.
Publicado: (2023)

Development of a Novel Clinical Decision Support System for Exercise Prescription Among Patients With Multiple Cardiovascular Disease Risk Factors
por: Pescatello, Linda S., et al.
Publicado: (2020)

Telehealth Intervention to Improve Uptake of Evidence-Based Medications among Patients with Type 2 Diabetes and Heart Failure or Cardiovascular Disease
por: Silva-Almodóvar, Armando, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_seeo2314sn93qqamrva7aln5fj